Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price
on Feb 6, 2026
Generation Bio Co. Revenue
Generation Bio Co. had revenue of $1.59M in the quarter ending September 30, 2025, a decrease of -78.90%. This brings the company's revenue in the last twelve months to $15.27M, down -17.82% year-over-year. In the year 2024, Generation Bio Co. had annual revenue of $19.89M with 236.92% growth.
Revenue (ttm)
$15.27M
Revenue Growth
-17.82%
P/S Ratio
2.34
Revenue / Employee
$132,783
Employees
115
Market Cap
36.04M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGBIO News
- 2 months ago - XOMA Royalty Enters into Agreement to Acquire Generation Bio - GlobeNewsWire
- 4 months ago - Generation Bio Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Generation Bio Announces CEO Transition - GlobeNewsWire
- 7 months ago - Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 months ago - Generation Bio Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 8 months ago - Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 months ago - Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 10 months ago - Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - GlobeNewsWire